Sanders-Brown Center on Aging

75%

Increase in Funding

NIH funding to the Sanders-Brown Center on Aging increased from $13.3 million to $23.4 million in one year, a remarkable 75% increase in funding.

125

Employees

Beginning with only three faculty members, the Center has grown to more than 125 employees and to be one of the nation's leading centers on aging.

Drug studied at UK is first disease-modifying therapy in U.S. approved to treat Alzheimer’s

On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.

Read the Full Story

SAVE THE DATE: Markesbery Symposium on Aging and Dementia

The thirteenth annual Markesbery Symposium will be Friday, Nov. 17 and Saturday, Nov. 18, 2023. Guest presenters for this year's symposium will be Dr. Malu Tansey & Dr. David Morgan. The symposium is named in honor and memory of the late William R. Markesbery, MD, founding director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center. Dr. Markesbery's legacy of groundbreaking research has formed the bedrock for our quest to understand and treat Alzheimer's disease and to improve the quality of life of the older adults. More details to come.